Covariate (univariate analyses) | HR | 95% CI | P |
---|---|---|---|
Ki-67 (Automated assessment of extent of staining) | |||
Low | 1.00 | ||
Moderate | 1.77 | 1.31-2.37 | < 0.0001 |
High | 2.34 | 1.76-3.10 | < 0.0001 |
Ki-67 (Visually assessed proliferation index) | |||
Negative | 1.00 | ||
Moderate | 1.41 | 0.83-2.39 | 0.207 |
High | 2.58 | 1.52-4.37 | < 0.0001 |
Covariate (multivariate analyses) | HR | 95% CI | P |
Ki-67 (Automated assessment of extent of staining) | |||
Low | 1.00 | ||
Moderate | 1.62 | 1.10-2.39 | 0.014 |
High | 1.73 | 1.19-2.51 | 0.004 |
Tumour size* | 1.23 | 1.14-1.34 | < 0.0001 |
No. of positive axillary lymph nodes† | 1.14 | 1.11-1.18 | < 0.0001 |
Histological grade (grade 3 or 2 vs. 1) | 2.17 | 1.36-3.47 | 0.001 |
Detection at mammography screening | 0.50 | 0.32-0.78 | 0.002 |
Age at diagnosis | |||
< 50 | 1.00 | ||
>50 | 1.18 | 0.90-1.55 | 0.221 |
Ki-67 (Visually assessed proliferation index) | |||
Negative | 1.00 | ||
Moderate | 0.71 | 0.37-1.38 | 0.311 |
High | 1.03 | 0.53-2.01 | 0.920 |
Tumour size* | 1.25 | 1.15-1.35 | < 0.0001 |
No. of positive axillary lymph nodes† | 1.14 | 1.11-1.18 | < 0.0001 |
Histological grade (grade 3 or 2 vs. 1) | 2.36 | 1.46-3.80 | < 0.0001 |
Detection at mammography screening | 0.47 | 0.30-0.74 | 0.001 |
Age at diagnosis | |||
< 50 | 1.00 | ||
>50 | 1.20 | 0.92-1.58 | 0.185 |